Stocks Above the 200-Day Moving Average — Financial View · Services-Commercial Physical & Biological Research
10 stocks match the Stocks Above the 200-Day Moving Average screen. Stocks trading above their 200-day moving average — a long-term uptrend filter, largest first. Financial columns. Filtered to Services-Commercial Physical & Biological Research. Updated
Filters2
1–10 of 10
| IQV | IQVIA | $45.3B | — | 4.7% | 22.3% | 6.9% | 0.75 | 2.25 | — | 13.2% | 8.3% | 271.67 | +2.95% | 119K |
| INCY | Incyte | $25.6B | — | 19.5% | 25.5% | 5.8% | 3.68 | 3.40 | 92.5% | 30.0% | 26.7% | 128.00 | -0.68% | 38K |
| MEDP | Medpace Holdings, Inc. | $16.6B | — | 23.9% | — | — | 0.73 | 0.00 | — | 21.0% | 17.7% | 593.43 | +0.09% | 7K |
| CRL | Charles River Laboratories | $14.0B | — | -3.2% | -8.4% | -5.4% | 1.35 | 0.57 | — | 2.3% | -6.0% | 293.29 | +0.54% | 36K |
| ABSI | Absci Corp | $1.5B | — | -45.0% | -49.2% | -48.4% | 10.63 | 0.02 | — | — | — | 8.79 | -0.06% | 112K |
| OABI | OmniAb, Inc. | $689M | — | -15.3% | -17.0% | -17.0% | 4.80 | 0.12 | — | — | — | 4.74 | -5.77% | 126K |
| NRC | Nrc Health | $470M | 2.6% | 8.5% | — | 12.5% | 0.65 | 13.13 | — | 10.5% | 8.3% | 21.25 | +6.23% | 10K |
| MXCT | MAXCYTE, INC. | $131M | — | -19.3% | -22.4% | -22.4% | 12.26 | 0.16 | — | — | — | 1.26 | -1.17% | 16K |
| BIAF | bioAffinity Technologies, Inc. | $100M | — | — | — | — | 1.44 | 1.02 | 0.1% | — | — | 12.37 | +22.48% | 415K |
| ICLR | Icon Plc | — | — | 1.1% | 1.9% | 1.4% | 1.14 | 0.31 | — | 1.3% | 2.1% | 163.59 | +2.36% | 42K |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.